
Sign up to save your podcasts
Or


Rachel K. King, co-founder and CEO of GlycoMimetics, Inc. (GMI), joins Rich Bendis to discuss being the CEO of a publicly traded clinical-stage biotechnology company, gene therapy, and the BioHealth Capital Region.
By BioHealth Innovation, Inc. (BHI)4.7
1111 ratings
Rachel K. King, co-founder and CEO of GlycoMimetics, Inc. (GMI), joins Rich Bendis to discuss being the CEO of a publicly traded clinical-stage biotechnology company, gene therapy, and the BioHealth Capital Region.

10,182 Listeners